Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn H Jones

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Molecular Biosystems|May 25, 2016
Protein labellingLyn H Jones, Eranthie Weerapana
Future Medicinal Chemistry|January 14, 2015
TAK1 selective inhibition: state of the art and future opportunitiesIain Kilty, Lyn H Jones
Pharmaceutical Patent Analyst|April 9, 2015
Click chemistry patents and their impact on drug discovery and chemical biologyHua Xu, Lyn H Jones
Science Translational Medicine|April 21, 2017
Clinical chemoproteomics-Opportunities and obstaclesLyn H Jones, Hendrik Neubert
RSC Medicinal Chemistry|November 3, 2022
Covalent drugs targeting histidine - an unexploited opportunity?Jianwei Che, Lyn H Jones
Future Medicinal Chemistry|September 28, 2011
Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary diseaseAdam D Hughes, Lyn H Jones
RSC Medicinal Chemistry|January 22, 2021
Structure-based design and analysis of SuFEx chemical probesLyn H Jones, Jeffery W Kelly
Clinical Pharmacology and Therapeutics|July 3, 2023
Clinical Translation of Targeted Protein DegradersNikki R Kong, Lyn H Jones
Progress in Medicinal Chemistry|February 7, 2013
Medicinal chemistry of glucagon-like peptide receptor agonistsLyn H Jones, David A Price
SLAS Discovery : Advancing Life Sciences R & D|December 18, 2020
Target Validation Using PROTACs: Applying the Four Pillars FrameworkRadosław P Nowak, Lyn H Jones
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Molecular Biosystems|May 25, 2016
Protein labellingLyn H Jones, Eranthie Weerapana
Future Medicinal Chemistry|January 14, 2015
TAK1 selective inhibition: state of the art and future opportunitiesIain Kilty, Lyn H Jones
Pharmaceutical Patent Analyst|April 9, 2015
Click chemistry patents and their impact on drug discovery and chemical biologyHua Xu, Lyn H Jones
Science Translational Medicine|April 21, 2017
Clinical chemoproteomics-Opportunities and obstaclesLyn H Jones, Hendrik Neubert
RSC Medicinal Chemistry|November 3, 2022
Covalent drugs targeting histidine - an unexploited opportunity?Jianwei Che, Lyn H Jones
Future Medicinal Chemistry|September 28, 2011
Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary diseaseAdam D Hughes, Lyn H Jones
RSC Medicinal Chemistry|January 22, 2021
Structure-based design and analysis of SuFEx chemical probesLyn H Jones, Jeffery W Kelly
Clinical Pharmacology and Therapeutics|July 3, 2023
Clinical Translation of Targeted Protein DegradersNikki R Kong, Lyn H Jones
Progress in Medicinal Chemistry|February 7, 2013
Medicinal chemistry of glucagon-like peptide receptor agonistsLyn H Jones, David A Price
SLAS Discovery : Advancing Life Sciences R & D|December 18, 2020
Target Validation Using PROTACs: Applying the Four Pillars FrameworkRadosław P Nowak, Lyn H Jones
Pageof 12